3 ms·
I think I read that Senator Wyden is the second largest taker of money from Big Pharma. Because of this, I am going to take a careful and critical look at his l
by mark_l_watson 2y ago
I think I read that Senator Wyden is the second largest taker of money from Big Pharma. Because of this, I am going to take a careful and critical look at his legislation.
To be fair, many politicians do both really good and really bad things. The world is not black and white.
- lrvick 2y agoTotal FUD. Wyden is no friend of big pharma. Probably one of the only couple of politicians we have left actually working for the people. https://www.finance.senate.gov/chairmans-news/wyden-expands-big-pharma-tax-investigation-with-pfizer-inquiry https://www.finance.senate.gov/chairmans-news/wyden-expands-...
- mark_l_watson 2y agoDo more research. He is a mixed bag, trying to lower prescription drug prices, but he is also no enemy of Big Pharma. I asked OpenAI about him in research mode, and if it was largely correct. So not total FUD. I am quoting from ChatGPT: Between 2019 and 2024, Senator Ron Wyden received $351,513 in campaign contributions from the Pharmaceuticals/Health Products industry. This total includes $169,063 from individual donors and $182,450 from political action committees (PACs). It’s important to note that while Senator Wyden has received contributions from the pharmaceutical industry, he has also been a critic of high drug prices. For instance, during a 2019 Senate Finance Committee hearing, he emphasized the need for concrete actions to make medications more affordable.
- digitalPhonix 2y agoI don't think that absolute dollar value a useful measure. From https://www.opensecrets.org/members-of-congress/ron-wyden/summary?cid=N00007724 https://www.opensecrets.org/members-of-congress/ron-wyden/su... Pharmaceuticals/Health Products is the 9th contributor (or about 3% of his campaign fundraising between 2019-2024). Is that big? I have no idea.
- currymj 2y agoif an individual pharma employee makes a donation as an individual, many of the datasets will classify it as “money from the pharmaceutical industry”. worth considering.
- bigfatkitten 2y agoAnd those individuals are typically well educated and well remunerated people, who as a cohort tend to lean Democrat.